Recent advances in intensity modulated radiotherapy and proton therapy for esophageal cancer

References

• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115–132.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7–30.
   PubMed Web of Science ®Google Scholar
• Lordick F, Mariette C, Haustermans K, et al. Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27(suppl 5):v50–v57.
   PubMed Web of Science ®Google Scholar
• Sjoquist KM, Burmeister BH, Smithers BM, et al. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol. 2011;12:681–692.
   PubMed Web of Science ®Google Scholar
• van Hagen P, Hulshof MC, van Lanschot JJ, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366:2074–2084.
   PubMed Web of Science ®Google Scholar
• Shapiro J, van Lanschot JJ, Hulshof MCCM, et al. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol. 2015;16:1090–1098.
   PubMed Web of Science ®Google Scholar
• Cooper JS, Guo MD, Herskovic A, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. Jama. 1999;281:1623–1627.
   PubMed Web of Science ®Google Scholar
• Frandsen J, Boothe D, Gaffney DK, et al. Increased risk of death due to heart disease after radiotherapy for esophageal cancer. J Gastrointest Oncol. 2015;6:516–523.
   PubMed Web of Science ®Google Scholar
• Gharzai L, Verma V, Denniston KA, et al. Radiation therapy and cardiac death in long-term survivors of esophageal cancer: an analysis of the surveillance, epidemiology, and end result database. PLoS One. 2016;11:e0158916.
   PubMed Web of Science ®Google Scholar
• Wang S-L, Liao Z, Vaporciyan AA, et al. Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys. 2006;64:692–699.
   PubMed Web of Science ®Google Scholar
• Wilke TJ, Bhirud AR, Lin C. A review of the impact of preoperative chemoradiotherapy on outcome and postoperative complications in esophageal cancer patients. Am J Clin Oncol. 2015;38:415–421.
   PubMed Web of Science ®Google Scholar
• Deng J-Y, Wang C, Shi X-H, et al. Reduced toxicity with three-dimensional conformal radiotherapy or intensity-modulated radiotherapy compared with conventional two-dimensional radiotherapy for esophageal squamous cell carcinoma: a secondary analysis of data from four prospective clinical trials. Dis Esophagus. 2016;29:1121–1127.
   PubMed Web of Science ®Google Scholar
• Verma V, Moreno AC, Lin SH. Advances in radiotherapy management of esophageal cancer. J Clin Med. 2016;5:E91.
   PubMed Web of Science ®Google Scholar
• Chuong MD, Hallemeier CL, Jabbour SK, et al. Improving outcomes for esophageal cancer using proton beam therapy. Int J Radiat Oncol Biol Phys. 2016;95:488–497.
   PubMed Web of Science ®Google Scholar
• Chandra A, Guerrero TM, Liu HH, et al. Feasibility of using intensity-modulated radiotherapy to improve lung sparing in treatment planning for distal esophageal cancer. Radiother Oncol. 2005;77:247–253.
   PubMed Web of Science ®Google Scholar
• Nutting CM, Bedford JL, Cosgrove VP, et al. A comparison of conformal and intensity-modulated techniques for oesophageal radiotherapy. Radiother Oncol. 2001;61:157–163.
   PubMed Web of Science ®Google Scholar
• Kole TP, Aghayere O, Kwah J, et al. Comparison of heart and coronary artery doses associated with intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for distal esophageal cancer. Int J Radiat Oncol Biol Phys. 2012;83:1580–1586.
   PubMed Web of Science ®Google Scholar
• Wu VW, Sham JS, Kwong DL. Inverse planning in three-dimensional conformal and intensity-modulated radiotherapy of mid-thoracic oesophageal cancer. Br J Radiol. 2004;77:568–572.
   PubMed Web of Science ®Google Scholar
• Fakhrian K, Oechsner M, Kampfer S, et al. Advanced techniques in neoadjuvant radiotherapy allow dose escalation without increased dose to the organs at risk: planning study in esophageal carcinoma. Strahlenther Onkol. 2013;189:293–300.
   PubMed Web of Science ®Google Scholar
• Zhang W-Z, Chen J-Z, Li D-R, et al. Simultaneous modulated accelerated radiation therapy for esophageal cancer: a feasibility study. World J Gastroenterol. 2014;20:13973–13980.
   PubMed Web of Science ®Google Scholar
• Wu Z, Xie C, Hu M, et al. Dosimetric benefits of IMRT and VMAT in the treatment of middle thoracic esophageal cancer: is the conformal radiotherapy still an alternative option? J Appl Clin Med Phys. 2014;15:93–101.
   PubMed Web of Science ®Google Scholar
• Fenkell L, Kaminsky I, Breen S, et al. Dosimetric comparison of IMRT vs. 3D conformal radiotherapy in the treatment of cancer of the cervical esophagus. Radiother Oncol. 2008;89:287–291.
   PubMed Web of Science ®Google Scholar
• Welsh JW, Seyedin SN, Hofstetter WL, et al. Prospective phase 1/2 clinical trial: evaluating dose-escalation for esophageal cancer. Int J Radiat Oncol Biol Phys. 2015;93:S12–S13.
   Web of Science ®Google Scholar
• He L, Allen PK, Potter A, et al. Re-evaluating the optimal radiation dose for definitive chemoradiotherapy for esophageal squamous cell carcinoma. J Thorac Oncol. 2014;9:1398–1405.
   PubMed Web of Science ®Google Scholar
• Brower JV, Chen S, Bassetti MF, et al. Radiation dose escalation in esophageal cancer revisited: a contemporary analysis of the National Cancer Data Base, 2004 to 2012. Int J Radiat Oncol Biol Phys. 2016;96:985–993.
   PubMed Web of Science ®Google Scholar
• Minsky BD, Pajak TF, Ginsberg RJ, et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol. 2002;20:1167–1174.
   PubMed Web of Science ®Google Scholar
• Roeder F, Nicolay NH, Nguyen T, et al. Intensity modulated radiotherapy (IMRT) with concurrent chemotherapy as definitive treatment of locally advanced esophageal cancer. Radiat Oncol. 2014;9:191.
   PubMed Web of Science ®Google Scholar
• Ge X, Yang X, Lu X, et al. Long-term clinical outcome of intensity-modulated radiation therapy for locally advanced esophageal squamous cell carcinoma. Tumori. 2015;101:168–173.
   PubMed Web of Science ®Google Scholar
• La TH, Minn AY, Su Z, et al. Multimodality treatment with intensity modulated radiation therapy for esophageal cancer. Dis Esophagus. 2010;23:300–308.
   PubMed Web of Science ®Google Scholar
• Tu L, Sun L, Xu Y, et al. Paclitaxel and cisplatin combined with intensity-modulated radiotherapy for upper esophageal carcinoma. Radiat Oncol. 2013;8:75.
   PubMed Web of Science ®Google Scholar
• Gerber N, Ilson DH, Wu AJ, et al. Outcomes of induction chemotherapy followed by chemoradiation using intensity-modulated radiation therapy for esophageal adenocarcinoma. Dis Esophagus. 2014;27:235–241.
   PubMed Web of Science ®Google Scholar
• Xu Y, Wang Z, Liu G, et al. The efficacy and safety of simultaneous integrated boost intensity-modulated radiation therapy for esophageal squamous cell carcinoma in Chinese population: a single institution experience. J Cancer Res Ther. 2016;12(Suppl):82–88.
   PubMed Web of Science ®Google Scholar
• Chen J, Guo H, Zhai T, et al. Radiation dose escalation by simultaneous modulated accelerated radiotherapy combined with chemotherapy for esophageal cancer: a phase II study. Oncotarget. 2016;7:22711–22719.
   PubMed Web of Science ®Google Scholar
• Yu W-W, Zhu Z-F, Fu X-L, et al. Simultaneous integrated boost intensity-modulated radiotherapy in esophageal carcinoma: early results of a phase II study. Strahlenther Onkol. 2014;190:979–986.
   PubMed Web of Science ®Google Scholar
• Freilich J, Hoffe SE, Almhanna K, et al. Comparative outcomes for three-dimensional conformal versus intensity-modulated radiation therapy for esophageal cancer. Dis Esophagus. 2015;28:352–357.
   PubMed Web of Science ®Google Scholar
• Lin SH, Wang L, Myles B, et al. Propensity score-based comparison of long-term outcomes with 3-dimensional conformal radiotherapy vs intensity-modulated radiotherapy for esophageal cancer. Int J Radiat Oncol Biol Phys. 2012;84:1078–1085.
   PubMed Web of Science ®Google Scholar
• He L, Chapple A, Liao Z, et al. Bayesian regression analyses of radiation modality effects on pericardial and pleural effusion and survival in esophageal cancer. Radiother Oncol. 2016;121:70–74.
   PubMed Web of Science ®Google Scholar
• Lin SH, Zhang N, Godby J, et al. Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer. Cancer. 2016;122:917–928.
   PubMed Web of Science ®Google Scholar
• Wang J, Wei C, Tucker SL, et al. Predictors of postoperative complications after trimodality therapy for esophageal cancer. Int J Radiat Oncol Biol Phys. 2013;86:885–891.
   PubMed Web of Science ®Google Scholar
• Yang H, Feng C, Cai BN, et al. Comparison of three-dimensional conformal radiation therapy, intensity-modulated radiation therapy, and volumetric-modulated arc therapy in the treatment of cervical esophageal carcinoma. Dis Esophagus. 2017;30:1–8.
   Google Scholar
• Makishima H, Ishikawa H, Terunuma T, et al. Comparison of adverse effects of proton and X-ray chemoradiotherapy for esophageal cancer using an adaptive dose-volume histogram analysis. J Radiat Res. 2015;56:568–576.
   PubMed Web of Science ®Google Scholar
• Chuong M, Bhooshan N, Allen PK, et al. A multi-institutional analysis of acute toxicity after neoadjuvant chemoradiation using photons or protons in trimodality esophageal cancer patients. Int J Radiat Oncol Biol Phys. 2015;93:S220.
   PubMed Web of Science ®Google Scholar
• Hallemeier CL, Chuong M, Merrell KW, et al. Impact of neoadjuvant proton vs. photon chemoradiotherapy on post-operative outcomes in patients with esophageal cancer treated with trimodality therapy: a multi-institutional analysis. Int J Particle Ther. 2015;2:79–80.
   Google Scholar
• Palma DA, Verbakel WFAR, Otto K, et al. New developments in arc radiation therapy: a review. Cancer Treat Rev. 2010;36:393–399.
   PubMed Web of Science ®Google Scholar
• Teoh M, Clark CH, Wood K, et al. Volumetric modulated arc therapy: a review of current literature and clinical use in practice. Br J Radiol. 2011;84:967–996.
   PubMed Web of Science ®Google Scholar
• Ma P, Wang X, Xu Y, et al. Applying the technique of volume-modulated arc radiotherapy to upper esophageal carcinoma. J Appl Clin Med Phys. 2014;15:221–228.
   Web of Science ®Google Scholar
• Kataria T, Govardhan HB, Gupta D, et al. Dosimetric comparison between Volumetric Modulated Arc Therapy (VMAT) vs Intensity Modulated Radiation Therapy (IMRT) for radiotherapy of mid esophageal carcinoma. J Cancer Res Ther. 2014;10:871–877.
   PubMed Web of Science ®Google Scholar
• Lin C-Y, Huang W-Y, Jen Y-M, et al. Dosimetric and efficiency comparison of high-dose radiotherapy for esophageal cancer: volumetric modulated arc therapy versus fixed-field intensity-modulated radiotherapy. Dis Esophagus. 2014;27:585–590.
   PubMed Web of Science ®Google Scholar
• Van Benthuysen L, Hales L, Podgorsak MB. Volumetric modulated arc therapy vs. IMRT for the treatment of distal esophageal cancer. Med Dosim. 2011;36:404–409.
   PubMed Web of Science ®Google Scholar
• Gao M, Li Q, Ning Z, et al. Dosimetric comparison between step-shoot intensity-modulated radiotherapy and volumetric-modulated arc therapy for upper thoracic and cervical esophageal carcinoma. Med Dosim. 2016;41:131–135.
   PubMed Web of Science ®Google Scholar
• Nicolini G, Ghosh-Laskar S, Shrivastava SK, et al. Volumetric modulation arc radiotherapy with flattening filter-free beams compared with static gantry IMRT and 3D conformal radiotherapy for advanced esophageal cancer: a feasibility study. Int J Radiat Oncol Biol Phys. 2012;84:553–560.
   PubMed Web of Science ®Google Scholar
• Lin JC, Tsai JT, Chang CC, et al. Comparing treatment plan in all locations of esophageal cancer: volumetric modulated arc therapy versus intensity-modulated radiotherapy. Medicine (Baltimore). 2015;94:e750.
   PubMed Web of Science ®Google Scholar
• Hawkins MA, Bedford JL, Warrington AP, et al. Volumetric modulated arc therapy planning for distal oesophageal malignancies. Br J Radiol. 2012;85:44–52.
   PubMed Web of Science ®Google Scholar
• Zhang WZ, Zhai TT, Lu JY, et al. Volumetric modulated arc therapy vs. c-IMRT for the treatment of upper thoracic esophageal cancer. PLoS One. 2015;10:e0121385.
   PubMed Web of Science ®Google Scholar
• Yin L, Wu H, Gong J, et al. Volumetric-modulated arc therapy vs. c-IMRT in esophageal cancer: a treatment planning comparison. World J Gastroenterol. 2012;18:5266–5275.
   PubMed Web of Science ®Google Scholar
• Münch S, Aichmeier S, Hapfelmeier A, et al. Comparison of dosimetric parameters and toxicity in esophageal cancer patients undergoing 3D conformal radiotherapy or VMAT. Strahlenther Onkol. 2016;192:722–729.
   PubMed Web of Science ®Google Scholar
• Newhauser WD, Zhang R. The physics of proton therapy. Phys Med Biol. 2015;60:R155–209.
   PubMed Web of Science ®Google Scholar
• Paganetti H, van Luijk P. Biological considerations when comparing proton therapy with photon therapy. Semin Radiat Oncol. 2013;23:77–87.
   PubMed Web of Science ®Google Scholar
• Isacsson U, Lennernäs B, Grusell E, et al. Comparative treatment planning between proton and x-ray therapy in esophageal cancer. Int J Radiat Oncol Biol Phys. 1998;41:441–450.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhao K-L, Guerrero TM, et al. Four-dimensional computed tomography-based treatment planning for intensity-modulated radiation therapy and proton therapy for distal esophageal cancer. Int J Radiat Oncol Biol Phys. 2008;72:278–287.
   PubMed Web of Science ®Google Scholar
• Ling TC, Slater JM, Nookala P, et al. Analysis of intensity-modulated radiation therapy (IMRT), proton and 3D conformal radiotherapy (3D-CRT) for reducing perioperative cardiopulmonary complications in esophageal cancer patients. Cancers (Basel). 2014;6:2356–2368.
   PubMed Web of Science ®Google Scholar
• Welsh J, Gomez D, Palmer MB, et al. Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: a dosimetric study. Int J Radiat Oncol Biol Phys. 2011;81:1336–1342.
   PubMed Web of Science ®Google Scholar
• Warren S, Partridge M, Bolsi A, et al. An analysis of plan robustness for esophageal tumors: comparing volumetric modulated arc therapy plans and spot scanning proton planning. Int J Radiat Oncol Biol Phys. 2016;95:199–207.
   PubMed Web of Science ®Google Scholar
• Chang JY, Li H, Zhu XR, et al. Clinical implementation of intensity modulated proton therapy for thoracic malignancies. Int J Radiat Oncol Biol Phys. 2014;90:809–818.
   PubMed Web of Science ®Google Scholar
• Yu J, Zhang X, Liao L, et al. Motion-robust intensity-modulated proton therapy for distal esophageal cancer. Med Phys. 2016;43:1111–1118.
   PubMed Web of Science ®Google Scholar
• Lin Y, Clasie B, Lu HM, et al. Impacts of gantry angle dependent scanning beam properties on proton PBS treatment. Phys Med Biol. 2016;62:344–357.
   PubMed Web of Science ®Google Scholar
• Doyen J, Falk AT, Floquet V, et al. Proton beams in cancer treatments: clinical outcomes and dosimetric comparisons with photon therapy. Cancer Treat Rev. 2016;43:104–112.
   PubMed Web of Science ®Google Scholar
• Koyama S, Tsujii H, Yokota H, et al. Proton beam therapy for patients with esophageal carcinoma. Jpn J Clin Oncol. 1994;24:144–153.
   PubMed Web of Science ®Google Scholar
• Koyama S, Tsujii H. Proton beam therapy with high-dose irradiation for superficial and advanced esophageal carcinomas. Clin Cancer Res. 2003;9:3571–3577.
   PubMed Web of Science ®Google Scholar
• Sugahara S, Tokuuye K, Okumura T, et al. Clinical results of proton beam therapy for cancer of the esophagus. Int J Radiat Oncol Biol Phys. 2005;61:76–84.
   PubMed Web of Science ®Google Scholar
• Mizumoto M, Sugahara S, Nakayama H, et al. Clinical results of proton-beam therapy for locoregionally advanced esophageal cancer. Strahlenther Onkol. 2010;186:482–488.
   PubMed Web of Science ®Google Scholar
• Mizumoto M, Sugahara S, Okumura T, et al. Hyperfractionated concomitant boost proton beam therapy for esophageal carcinoma. Int J Radiat Oncol Biol Phys. 2011;81:e601–606.
   PubMed Web of Science ®Google Scholar
• Ono T, Nakamura T, Azami Y, et al. Clinical results of proton beam therapy for twenty older patients with esophageal cancer. Radiol Oncol. 2015;49:371–378.
   PubMed Web of Science ®Google Scholar
• Lin SH, Komaki R, Liao Z, et al. Proton beam therapy and concurrent chemotherapy for esophageal cancer. Int J Radiat Oncol Biol Phys. 2012;83:e345–e351.
   PubMed Web of Science ®Google Scholar
• Takada A, Nakamura T, Takayama K, et al. Preliminary treatment results of proton beam therapy with chemoradiotherapy for stage I-III esophageal cancer. Cancer Med. 2016;5:506–515.
   PubMed Web of Science ®Google Scholar
• Ishikawa H, Hashimoto T, Moriwaki T, et al. Proton beam therapy combined with concurrent chemotherapy for esophageal cancer. Anticancer Res. 2015;35:1757–1762.
   PubMed Web of Science ®Google Scholar
• Zeng Y-C, Vyas S, Dang Q, et al. Proton therapy posterior beam approach with pencil beam scanning for esophageal cancer: clinical outcome, dosimetry, and feasibility. Strahlenther Onkol. 2016;192:913–921.
   PubMed Web of Science ®Google Scholar
• Echeverria AE, McCurdy M, Castillo R, et al. Proton therapy radiation pneumonitis local dose-response in esophagus cancer patients. Radiother Oncol. 2013;106:124–129.
   PubMed Web of Science ®Google Scholar
• Fernandes A, Berman AT, Mick R, et al. A prospective study of proton beam reirradiation for esophageal cancer. Int J Radiat Oncol Biol Phys. 2016;95:483–487.
   PubMed Web of Science ®Google Scholar
• Lin SH, Merrell KW, Shen J, et al. Multi-institutional analysis of radiation modality use and postoperative outcomes of neoadjuvant chemoradiation for esophageal cancer. Radiother Oncol. Forthcoming 2017.
   Google Scholar
• Kwong Y, Mel AO, Wheeler G, et al. Four-dimensional computed tomography (4DCT): a review of the current status and applications. J Med Imaging Radiat Oncol. 2015;59:545–554.
   PubMed Web of Science ®Google Scholar
• Yamashita H, Kida S, Sakumi A, et al. Four-dimensional measurement of the displacement of internal fiducial markers during 320-multislice computed tomography scanning of thoracic esophageal cancer. Int J Radiat Oncol Biol Phys. 2011;79:588–595.
   PubMed Web of Science ®Google Scholar
• Jin P, Hulshof MCCM, de Jong R, et al. Quantification of respiration-induced esophageal tumor motion using fiducial markers and four-dimensional computed tomography. Radiother Oncol. 2016;118:492–497.
   PubMed Web of Science ®Google Scholar
• Zhao K-L, Liao Z, Bucci MK, et al. Evaluation of respiratory-induced target motion for esophageal tumors at the gastroesophageal junction. Radiother Oncol. 2007;84:283–289.
   PubMed Web of Science ®Google Scholar
• Patel AA, Wolfgang JA, Niemierko A, et al. Implications of respiratory motion as measured by four-dimensional computed tomography for radiation treatment planning of esophageal cancer. Int J Radiat Oncol Biol Phys. 2009;74:290–296.
   PubMed Web of Science ®Google Scholar